Acutus Medical, Inc.
AFIB · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 181.4% | 136.4% | -82.4% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 5% | -43.8% | -63% | -90.7% |
| EBITDA | $0 | -$0 | $0 | -$0 |
| % Margin | 11.2% | -74.4% | 1,161.5% | -608.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -47.4% | -1,139.9% | -1,307% | -681.7% |
| EPS Diluted | -0.32 | -2.81 | -1.39 | -4.11 |
| % Growth | 88.6% | -102.2% | 66.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |